# Tarka vs. Hyzaar in Patients With Metabolic Syndrome (STAR)

> **NCT00234858** · PHASE4 · COMPLETED · sponsor: **Abbott** · enrollment: 280 (actual)

## Conditions studied

- Hypertension
- Metabolic Syndrome

## Interventions

- **DRUG:** trandolapril/verapamil
- **DRUG:** (Hyzaar) losartan/hydrochlorothiazide

## Key facts

- **NCT ID:** NCT00234858
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03
- **Primary completion:** 2006-04
- **Final completion:** —
- **Target enrollment:** 280 (ACTUAL)
- **Last updated:** 2008-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00234858

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00234858, "Tarka vs. Hyzaar in Patients With Metabolic Syndrome (STAR)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00234858. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*